Background
Objective
Methods
Results
Conclusion
Graphical abstract

Keywords
Introduction
Methods
Animal model
Optical mapping
Cardiac electrical stimulation

Ex vivo VF induction and defibrillation protocol
Computer simulations

In silico VF induction and defibrillation protocol
Data analysis
Statistical analysis
Results
Ex vivo VF induction and dynamics


Ex vivo defibrillation

In silico VF induction and dynamics
In silico defibrillation
Line (cm) | Success (%) | EG capture (%) | EG line occupancy (%) | ||||||
---|---|---|---|---|---|---|---|---|---|
S | F8 | dF8 | S | F8 | dF8 | S | F8 | dF8 | |
0.25 | 100 | 100 | 100 | 100.0 ± 0.0 | 100.0 ± 0.0 | 100.0 ± 0.0 | 41.7 ± 0.10 | 41.5 ± 0.14 | 41.7 ± 0.01 |
0.5 | 62.5 | 56.5 | 67.5 | 59.4 ± 1.93 | 59.6 ± 1.63 | 60.6 ± 5.10 | 18.3 ± 0.03 | 18.1 ± 0.10 | 17.3 ± 0.15 |
1 | 35.5 | 40.5 | 47.5 | 27.4 ± 3.18 | 29.3 ± 3.89 | 29.3 ± 12.5 | 9.81 ± 0.25 | 9.79 ± 0.16 | 9.04 ± 0.26 |
2 | 20.5 | 24.5 | 19.5 | 16.1 ± 4.43 | 16.7 ± 4.50 | 10.3 ± 5.78 | 5.80 ± 0.35 | 5.06 ± 0.27 | 4.14 ± 0.24 |

In silico defibrillation mechanisms
Discussion
Defibrillation with low-energy surface stimulation is painless
Low-energy defibrillation success depends on arrhythmia complexity
Clinical and experimental significance
Study limitations
Ex vivo
In silico
Vigmond EJ, Boyle PM, Deo M. The role of the Purkinje system in defibrillation. In Trayanova NA, Editor. Cardiac Defibrillation—Mechanisms, Challenges and Implications. InTechOpen, September 26, 2011, pp 10–26. doi: 10.5772/25267. Available from: https://www.intechopen.com/chapters/20950.
Conclusion
Appendix. Supplementary data
- Supplemental Material
References
- The spectrum of epidemiology underlying sudden cardiac death.Circ Res. 2015; 116: 1887-1906
- Internal defibrillation: pain perception of low energy shocks.Pacing Clin Electrophysiol. 2002; 25: 1090-1093
- Quality of life and psychological functioning of ICD patients.Heart. 2002; 87: 488
- Effects of strong electrical shock on cardiac muscle tissue.Ann N Y Acad Sci. 1994; 720: 160-175
- Inappropriate implantable cardioverter-defibrillator shocks in MADIT II. Frequency, mechanisms, predictors, and survival impact.J Am Coll Cardiol. 2008; 51: 13571365
- Low-energy defibrillation with nanosecond electric shocks.Cardiovasc Res. 2017; 113: 1789-1797
- Synchronization as a mechanism for low-energy anti-fibrillation pacing.Heart Rhythm. 2017; 14: 1254-1262
- Optogenetic defibrillation terminates ventricular arrhythmia in mouse hearts and human simulations.J Clin Invest. 2016; 126: 3894-3904
- Wide-area low-energy surface stimulation of large mammalian ventricular tissue.Sci Rep. 2019; 9: 15863
- Significant differences in charge times among currently available implantable cardioverter defibrillators.Pacing Clin Electrophysiol. 1999; 22: 903-907
- Spectral analysis identifies sites of high-frequency activity maintaining atrial fibrillation in humans.Circulation. 2005; 112: 789-797
- Relation between total shock energy and mortality in patients with implantable cardioverter-defibrillator.Int J Cardiol. 2018; 259: 94-99
- Distribution of excitation frequencies on the epicardial and endocardial surfaces of fibrillating ventricular wall of the sheep heart.Circ Res. 2000; 86: 408-417
- Insights into the spatiotemporal patterns of complexity of ventricular fibrillation by multilead analysis of body surface potential maps.Front Physiol. 2020; 11: 1-15
- Calcium dynamics and the mechanisms of ventricular tachycardia to ventricular fibrillation transition in cryoablated rabbit ventricles.Int J Arrhythm. 2015; 16: 11-18
- Cardiac fibrillation: from ion channels to rotors in the human heart.Heart Rhythm. 2008; 5: 872-879
- Ventricular fibrillation scaling exponent can guide timing of defibrillation and other therapies.Circulation. 2004; 109: 926-931
- Terminating ventricular tachyarrhythmias using far-field low-voltage stimuli: mechanisms and delivery protocols.Heart Rhythm. 2013; 10: 1209-1217
- Synchronization of ventricular fibrillation with real-time feedback pacing: implication to low-energy defibrillation.Am J Physiol Heart Circ Physiol. 2003; 285: 2704-2711
- Preshock phase singularity and the outcome of ventricular defibrillation.Heart Rhythm. 2007; 4: 927-934
- Mechanistic inquiry into decrease in probability of defibrillation success with increase in complexity of preshock reentrant activity.Am J Physiol Heart Circ Physiol. 2004; 286: 909-917
- Antitachycardia pacing for reduction of implantable cardioverter-defibrillator shocks.Heart Rhythm. 2015; 12: 1370-1375
- Termination of ventricular fibrillation in dogs by depolarizing a critical amount of myocardium.Am J Cardiol. 1975; 36: 37-44
- 3D multifunctional integumentary membranes for spatiotemporal cardiac measurements and stimulation across the entire epicardium.Nat Commun. 2014; 5: 3329
- Monitoring intramyocardial reentry using alternating transillumination.Conf Proc IEEE Eng Med Biol Soc. 2009; 2009: 4194
- Dynamical anchoring of distant arrhythmia sources by fibrotic regions via restructuring of the activation pattern.PLoS Comput Biol. 2018; 14: 1-19
Vigmond EJ, Boyle PM, Deo M. The role of the Purkinje system in defibrillation. In Trayanova NA, Editor. Cardiac Defibrillation—Mechanisms, Challenges and Implications. InTechOpen, September 26, 2011, pp 10–26. doi: 10.5772/25267. Available from: https://www.intechopen.com/chapters/20950.
- A simulation study of the effects of cardiac anatomy in ventricular fibrillation.J Clin Invest. 2004; 113: 686-693
- Computational rabbit models to investigate the initiation, perpetuation, and termination of ventricular arrhythmia.Prog Biophys Mol Biol. 2016; 121: 185-194
Article info
Publication history
Footnotes
Funding Sources: This work was supported by the French National Research Agency (Grant Numbers ANR-10-IAHU-04 and ANR-16-CE19-0009) and the Leducq Foundation (Grant Number 16CVD02 RHYTHM). Disclosures: Dr Vigmond is a co-founder of CardioSolv, LLC. CardioSolv was not involved in this research. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Identification
Copyright
User license
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |
Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy